BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20124474)

  • 1. CLOCK in breast tumorigenesis: genetic, epigenetic, and transcriptional profiling analyses.
    Hoffman AE; Yi CH; Zheng T; Stevens RG; Leaderer D; Zhang Y; Holford TR; Hansen J; Paulson J; Zhu Y
    Cancer Res; 2010 Feb; 70(4):1459-68. PubMed ID: 20124474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic and epigenetic associations of circadian gene TIMELESS and breast cancer risk.
    Fu A; Leaderer D; Zheng T; Hoffman AE; Stevens RG; Zhu Y
    Mol Carcinog; 2012 Dec; 51(12):923-9. PubMed ID: 22006848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The core circadian gene Cryptochrome 2 influences breast cancer risk, possibly by mediating hormone signaling.
    Hoffman AE; Zheng T; Yi CH; Stevens RG; Ba Y; Zhang Y; Leaderer D; Holford T; Hansen J; Zhu Y
    Cancer Prev Res (Phila); 2010 Apr; 3(4):539-48. PubMed ID: 20233903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of circadian clock gene expression is associated with tumor progression in breast cancer.
    Cadenas C; van de Sandt L; Edlund K; Lohr M; Hellwig B; Marchan R; Schmidt M; Rahnenführer J; Oster H; Hengstler JG
    Cell Cycle; 2014; 13(20):3282-91. PubMed ID: 25485508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circadian and melatonin disruption by exposure to light at night drives intrinsic resistance to tamoxifen therapy in breast cancer.
    Dauchy RT; Xiang S; Mao L; Brimer S; Wren MA; Yuan L; Anbalagan M; Hauch A; Frasch T; Rowan BG; Blask DE; Hill SM
    Cancer Res; 2014 Aug; 74(15):4099-110. PubMed ID: 25062775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circadian gene expression and clinicopathologic correlates in pancreatic cancer.
    Relles D; Sendecki J; Chipitsyna G; Hyslop T; Yeo CJ; Arafat HA
    J Gastrointest Surg; 2013 Mar; 17(3):443-50. PubMed ID: 23254314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CLOCK is a substrate of SUMO and sumoylation of CLOCK upregulates the transcriptional activity of estrogen receptor-α.
    Li S; Wang M; Ao X; Chang AK; Yang C; Zhao F; Bi H; Liu Y; Xiao L; Wu H
    Oncogene; 2013 Oct; 32(41):4883-91. PubMed ID: 23160374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case-control study of shift-work and breast cancer risk in Danish nurses: impact of shift systems.
    Hansen J; Stevens RG
    Eur J Cancer; 2012 Jul; 48(11):1722-9. PubMed ID: 21852111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock.
    Dong Z; Zhang G; Qu M; Gimple RC; Wu Q; Qiu Z; Prager BC; Wang X; Kim LJY; Morton AR; Dixit D; Zhou W; Huang H; Li B; Zhu Z; Bao S; Mack SC; Chavez L; Kay SA; Rich JN
    Cancer Discov; 2019 Nov; 9(11):1556-1573. PubMed ID: 31455674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Core Circadian Clock Genes Regulate Leukemia Stem Cells in AML.
    Puram RV; Kowalczyk MS; de Boer CG; Schneider RK; Miller PG; McConkey M; Tothova Z; Tejero H; Heckl D; Järås M; Chen MC; Li H; Tamayo A; Cowley GS; Rozenblatt-Rosen O; Al-Shahrour F; Regev A; Ebert BL
    Cell; 2016 Apr; 165(2):303-16. PubMed ID: 27058663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer risk, nightwork, and circadian clock gene polymorphisms.
    Truong T; Liquet B; Menegaux F; Plancoulaine S; Laurent-Puig P; Mulot C; Cordina-Duverger E; Sanchez M; Arveux P; Kerbrat P; Richardson S; Guénel P
    Endocr Relat Cancer; 2014 Aug; 21(4):629-38. PubMed ID: 24919398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of the clock genes polymorphisms with colorectal cancer susceptibility.
    Karantanos T; Theodoropoulos G; Gazouli M; Vaiopoulou A; Karantanou C; Stravopodis DJ; Bramis K; Lymperi M; Pektasidis D
    J Surg Oncol; 2013 Dec; 108(8):563-7. PubMed ID: 24037774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylation in necrotizing enterocolitis.
    Frazer LC; Yamaguchi Y; Singh DK; Akopyants NS; Good M
    Expert Rev Mol Med; 2024 Apr; 26():e16. PubMed ID: 38557638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How Does Chronobiology Contribute to the Development of Diseases in Later Life.
    Stowe TA; McClung CA
    Clin Interv Aging; 2023; 18():655-666. PubMed ID: 37101656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship Between Breast Cancer Risk and Polymorphisms in CLOCK Gene: A Systematic Review and Meta-Analysis.
    Shi Y; Wu L; Ji X; Li Y; Zhang Z
    Biochem Genet; 2023 Dec; 61(6):2348-2362. PubMed ID: 37036639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryptochrome 2 acetylation attenuates its antiproliferative effect in breast cancer.
    Xia K; Li S; Yang Y; Shi X; Zhao B; Lv L; Xin Z; Kang J; Ren P; Wu H
    Cell Death Dis; 2023 Apr; 14(4):250. PubMed ID: 37024472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity, cancer risk, and time-restricted eating.
    Das M; Webster NJG
    Cancer Metastasis Rev; 2022 Sep; 41(3):697-717. PubMed ID: 35984550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding the significance of biological clock and its impact on cancer incidence.
    Malik S; Stokes Iii J; Manne U; Singh R; Mishra MK
    Cancer Lett; 2022 Feb; 527():80-94. PubMed ID: 34906624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the impact of night shift work on methylation of circadian genes.
    Ritonja JA; Aronson KJ; Flaten L; Topouza DG; Duan QL; Durocher F; Tranmer JE; Bhatti P
    Epigenetics; 2022 Oct; 17(10):1259-1268. PubMed ID: 34825628
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.